Hello, and welcome to Regeneron Pharmaceuticals' fourth quarter 2024 earnings conference call. My name is Tawanda, and I will be your operator for today's call. (Operator Instructions) Please note ...

Sales of Eylea, which the company co-developed with Bayer (DE:BAYA), rose 2% to $1.495 billion. Sales of the higher-dose, longer-lasting formulation Eylea HD rose 148% to $305 million in the U.S., ...

Regeneron beat Q4 estimates with $12.07 EPS and $3.79B in sales. The company announced a dividend, a $3 billion buyback, and continued R&D investments.

EYLEA HD is anticipated to gain traction with the launch of a prefilled syringe in mid-2025 and label expansions for macular edema and extended dosing intervals. Management believes these developments ...

Despite lackluster sales of Eylea’s high-dose formulation and Sanofi-partnered Dupixent, Regeneron beat Q4 forecasts overall ...

Reports Q4 revenue $3.79B, consensus $3.75B. “Regeneron’s (REGN) financial and commercial strength allows for continued investment in our ...

Los Angeles Clippers star forward Kawhi Leonard has stepped away from the team in order to help members of his family who were forced to evacuate due to the Southern California wildfires ...

One of Kawhi Leonard‘s defining traits as both a player and a person is his honesty. Though he speaks softly, it’s clear he remains acutely aware of his performance and the challenges he faces. After ...

INGLEWOOD, Calif. — LA Clippers power forward Kawhi Leonard had his breakout game Wednesday night at home against the Brooklyn Nets, scoring a season-high 23 points in just under 24 minutes to ...

Riley Leonard needed a new team and Notre Dame needed a new quarterback. It ended up being the perfect match. Capital One Orange Bowl - Penn State v Notre Dame / Michael Pimentel/ISI Photos ...

This game featured Kawhi Leonard’s best performance of the season, as the two-time Finals MVP scored 23 points in 24 minutes. Playing just his fourth game of the season, Leonard looked the most ...

(pic credit: X) Leonard Schleifer is the CEO of Regeneron Pharmaceuticals, and his annual package is $452.9 million (approximately ₹3,896.24 crore). (pic credit: X) Marc Benioff is the CEO of ...